Skip to content

Clinical trials

Phase 1 Neuroblastoma trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuroblastoma Phase: Phase 1 Country / region: Canada Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20031
20061
20091
20101
20135
20141
20151
20172
20192
20212
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Active, not recruiting3
Withdrawn2
Not yet recruiting1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
New Approaches to Neuroblastoma Therapy Consortium7
Children's Oncology Group4
National Cancer Institute (NCI)4
AbbVie1
C17 Council1
Cellectar Biosciences, Inc.1
Dana-Farber Cancer Institute1
Michel Duval1
NCIC Clinical Trials Group1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuroblastoma22
Sarcoma4
Lymphoma3
Medulloblastoma3
Osteosarcoma3
Rhabdoid Tumor3
Brain Neoplasms2
Central Nervous System Neoplasms2
Leukemia, Myeloid, Acute2
Lymphoma, Large-Cell, Anaplastic2

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.